Acute Myeloid Leukemia
Aggressive cancer of myeloid blood cells. Treatment based on risk stratification and increasingly on molecular markers (FLT3, IDH1/2, NPM1, TP53).
No Insights found for this cancer type.
Aggressive cancer of myeloid blood cells. Treatment based on risk stratification and increasingly on molecular markers (FLT3, IDH1/2, NPM1, TP53).
No Insights found for this cancer type.